Altimmune (ALT) Total Debt (2012 - 2026)

Altimmune (ALT) has reported Total Debt for 14 consecutive years, with $34.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Debt changed N/A year-over-year to $34.5 million; the TTM figure through Mar 2026 stood at $34.5 million (changed N/A YoY), while the FY2025 annual figure was $34.3 million, changed N/A from the prior year.
• Total Debt advanced to $34.5 million in Q1 2026 per ALT's latest filing, from $34.3 million in the prior quarter.
• Across five years, Total Debt topped out at $34.5 million in Q1 2026 and bottomed at $1.5 million in Q2 2022.
• Historically, Total Debt has averaged $11.5 million across 4 years, with a median of $4.6 million in 2022.
• On a YoY basis, Total Debt climbed as much as 247.67% in 2022 and fell as far as 39.28% in 2022.
• Altimmune's Total Debt stood at $4.6 million in 2022, then declined by 6.02% to $4.3 million in 2023, then soared by 696.45% to $34.3 million in 2025, then gained by 0.64% to $34.5 million in 2026.
• Business Quant data shows ALT's Total Debt at $34.5 million in Q1 2026, $34.3 million in Q4 2025, and $14.4 million in Q3 2025.